An AsCas12f-based compact genome-editing tool derived by deep mutational scanning and structural analysis-Reference-Cited by-同舟云学术

An AsCas12f-based compact genome-editing tool derived by deep mutational scanning and structural analysis

Published:2023-10 Issue:22 Volume:186 Page:4920-4935.e23
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Hino Tomohiro,Omura Satoshi N.,Nakagawa Ryoya,Togashi Tomoki,Takeda Satoru N.,Hiramoto Takafumi,Tasaka Satoshi,Hirano Hisato,Tokuyama Takeshi,Uosaki Hideki,Ishiguro Soh,Kagieva Madina,Yamano Hiroyuki,Ozaki Yuki,Motooka Daisuke,Mori Hideto,Kirita Yuhei,Kise Yoshiaki,Itoh Yuzuru,Matoba Satoaki,Aburatani Hiroyuki,Yachie Nozomu,Karvelis Tautvydas,Siksnys Virginijus,Ohmori Tsukasa,Hoshino Atsushi,Nureki Osamu^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference51 articles.

1. The biology of CRISPR-Cas: backward and forward;Hille;Cell,2018

2. Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants;Makarova;Nat. Rev. Microbiol.,2020

3. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria;Gasiunas;Proc. Natl. Acad. Sci. USA,2012

4. A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity;Jinek;Science,2012

5. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system;Zetsche;Cell,2015

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic delivery of engineered compact AsCas12f by a positive-strand RNA virus vector enables highly efficient targeted mutagenesis in plants;Frontiers in Plant Science;2024-09-10

2. The type V effectors for CRISPR/Cas-mediated genome engineering in plants;Biotechnology Advances;2024-09

3. Next-generation CRISPR technology for genome, epigenome and mitochondrial editing;Transgenic Research;2024-08-19

4. Engineered IscB–ωRNA system with expanded target range for base editing;Nature Chemical Biology;2024-08-15

5. Intraparenchymal delivery of adeno-associated virus vectors for the gene therapy of neurological diseases;Expert Opinion on Biological Therapy;2024-07-31